-
Je něco špatně v tomto záznamu ?
Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection
LC. Assis, AA. de Castro, JPA. de Jesus, E. Nepovimova, K. Kuca, TC. Ramalho, FA. La Porta
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- chinoliny chemie terapeutické užití MeSH
- COVID-19 MeSH
- farmakoterapie COVID-19 MeSH
- počítačová simulace MeSH
- preklinické hodnocení léčiv MeSH
- SARS-CoV-2 chemie MeSH
- simulace molekulární dynamiky MeSH
- simulace molekulového dockingu MeSH
- teorie funkcionálu hustoty MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A new and more aggressive strain of coronavirus, known as SARS-CoV-2, which is highly contagious, has rapidly spread across the planet within a short period of time. Due to its high transmission rate and the significant time-space between infection and manifestation of symptoms, the WHO recently declared this a pandemic. Because of the exponentially growing number of new cases of both infections and deaths, development of new therapeutic options to help fight this pandemic is urgently needed. The target molecules of this study were the nitro derivatives of quinoline and quinoline N-oxide. Computational design at the DFT level, docking studies, and molecular dynamics methods as a well-reasoned strategy will aid in elucidating the fundamental physicochemical properties and molecular functions of a diversity of compounds, directly accelerating the process of discovering new drugs. In this study, we discovered isomers based on the nitro derivatives of quinoline and quinoline N-oxide, which are biologically active compounds and may be low-cost alternatives for the treatment of infections induced by SARS-CoV-2.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011424
- 003
- CZ-PrNML
- 005
- 20210507104447.0
- 007
- ta
- 008
- 210420s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-021-85280-9 $2 doi
- 035 __
- $a (PubMed)33737545
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Assis, Letícia C $u Department of Chemistry, Federal University of Lavras, Lavras, Minas Gerais, CEP 37200-000, Brazil
- 245 10
- $a Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection / $c LC. Assis, AA. de Castro, JPA. de Jesus, E. Nepovimova, K. Kuca, TC. Ramalho, FA. La Porta
- 520 9_
- $a A new and more aggressive strain of coronavirus, known as SARS-CoV-2, which is highly contagious, has rapidly spread across the planet within a short period of time. Due to its high transmission rate and the significant time-space between infection and manifestation of symptoms, the WHO recently declared this a pandemic. Because of the exponentially growing number of new cases of both infections and deaths, development of new therapeutic options to help fight this pandemic is urgently needed. The target molecules of this study were the nitro derivatives of quinoline and quinoline N-oxide. Computational design at the DFT level, docking studies, and molecular dynamics methods as a well-reasoned strategy will aid in elucidating the fundamental physicochemical properties and molecular functions of a diversity of compounds, directly accelerating the process of discovering new drugs. In this study, we discovered isomers based on the nitro derivatives of quinoline and quinoline N-oxide, which are biologically active compounds and may be low-cost alternatives for the treatment of infections induced by SARS-CoV-2.
- 650 _2
- $a COVID-19 $7 D000086382
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a teorie funkcionálu hustoty $7 D000077318
- 650 _2
- $a preklinické hodnocení léčiv $7 D004353
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a chinoliny $x chemie $x terapeutické užití $7 D011804
- 650 _2
- $a SARS-CoV-2 $x chemie $7 D000086402
- 650 _2
- $a farmakoterapie COVID-19 $7 D000093485
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a de Castro, Alexandre A $u Department of Chemistry, Federal University of Lavras, Lavras, Minas Gerais, CEP 37200-000, Brazil
- 700 1_
- $a de Jesus, João P A $u Laboratório de Nanotecnologia E Química Computacional, Universidade Tecnológica Federal Do Paraná, Londrina, PR, 86036-370, Brazil
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Králové, Czech Republic
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Králové, Czech Republic. kamil.kuca@uhk.cz
- 700 1_
- $a Ramalho, Teodorico C $u Department of Chemistry, Federal University of Lavras, Lavras, Minas Gerais, CEP 37200-000, Brazil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Králové, Czech Republic
- 700 1_
- $a La Porta, Felipe A $u Laboratório de Nanotecnologia E Química Computacional, Universidade Tecnológica Federal Do Paraná, Londrina, PR, 86036-370, Brazil. felipe_laporta@yahoo.com.br
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 11, č. 1 (2021), s. 6397
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33737545 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507104445 $b ABA008
- 999 __
- $a ok $b bmc $g 1649957 $s 1131803
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 1 $d 6397 $e 20210318 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210420